229 related articles for article (PubMed ID: 25083072)
1. Novel findings about management of gastric cancer: a summary from 10th IGCC.
Penon D; Cito L; Giordano A
World J Gastroenterol; 2014 Jul; 20(27):8986-92. PubMed ID: 25083072
[TBL] [Abstract][Full Text] [Related]
2. Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011.
Rausei S; Dionigi G; Sano T; Sasako M; Biondi A; Morgagni P; Garofalo A; Boni L; Frattini F; D'Ugo D; Preston S; Marrelli D; Degiuli M; Capella C; Sacco R; Ruspi L; De Manzoni G; Roviello F; Pinotti G; Rovera F; Noh SH; Coit D; Dionigi R
Ann Surg Oncol; 2013 Nov; 20(12):3942-7. PubMed ID: 23838909
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations in gastric cancer with special reference to the early-onset subtype.
Skierucha M; Milne AN; Offerhaus GJ; Polkowski WP; Maciejewski R; Sitarz R
World J Gastroenterol; 2016 Feb; 22(8):2460-74. PubMed ID: 26937134
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic mechanisms in gastric cancer.
Shi J; Qu YP; Hou P
World J Gastroenterol; 2014 Oct; 20(38):13804-19. PubMed ID: 25320518
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
6. Review of recent molecular landscape knowledge of gastric cancer.
Shimizu D; Kanda M; Kodera Y
Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
[TBL] [Abstract][Full Text] [Related]
7. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
8. Companion diagnostics for the targeted therapy of gastric cancer.
Yoo C; Park YS
World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.
Carlomagno N; Incollingo P; Tammaro V; Peluso G; Rupealta N; Chiacchio G; Sandoval Sotelo ML; Minieri G; Pisani A; Riccio E; Sabbatini M; Bracale UM; Calogero A; Dodaro CA; Santangelo M
Biomed Res Int; 2017; 2017():7869802. PubMed ID: 29094049
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and molecular features associated with patient age in gastric cancer.
Seo JY; Jin EH; Jo HJ; Yoon H; Shin CM; Park YS; Kim N; Jung HC; Lee DH
World J Gastroenterol; 2015 Jun; 21(22):6905-13. PubMed ID: 26078567
[TBL] [Abstract][Full Text] [Related]
12. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
13. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
14. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
15. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
16. Causes and consequences of microsatellite instability in gastric carcinogenesis.
Velho S; Fernandes MS; Leite M; Figueiredo C; Seruca R
World J Gastroenterol; 2014 Nov; 20(44):16433-42. PubMed ID: 25469011
[TBL] [Abstract][Full Text] [Related]
17. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
18. Genetics/genomics/proteomics of gastric adenocarcinoma.
Uppal DS; Powell SM
Gastroenterol Clin North Am; 2013 Jun; 42(2):241-60. PubMed ID: 23639639
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
[TBL] [Abstract][Full Text] [Related]
20. Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.
Li TT; Qiu F; Qian ZR; Wan J; Qi XK; Wu BY
World J Gastroenterol; 2014 Jan; 20(1):118-25. PubMed ID: 24415864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
